Abbott Laboratories (ABT) Social Stream



Abbott Laboratories (ABT): $109.00

-0.25 (-0.23%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Abbott Laboratories (ABT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ABT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-27 15 $146 $125 $136.846 $116.11 17.86%
2021-12-10 15 $146 $125 $137.846 $116.11 18.72%
2021-12-22 14 $150 $125 $138.583 $116.11 19.35%
2022-01-24 14 $157 $125 $140.333 $116.11 20.86%
2022-01-27 14 $151 $125 $139.25 $116.11 19.93%
2022-03-01 14 $151 $125 $139.307 $116.11 19.98%

The Trend in the Analyst Price Target


Over the past 21 months, ABT's average price target has gone up $37.5.

Over the past 50 weeks, ABT's average upside potential has been 8.61%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 14 158 111 135.670 120.90 12.22%
2021-05-15 22 158 120 136.320 118.31 15.22%
2021-06-26 25 158 110 126.300 112.72 12.05%
2021-12-10 14 146 125 137.250 134.37 2.14%
2021-12-10 15 146 125 137.846 134.37 2.59%

ABT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.29 11 2 1 0 0 14

The Trend in the Broker Recommendations


ABT's average broker recommendation rating improved by 0.54 over the prior 43 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Abbott Laboratories's variance in analysts' estimates is lower than 31.41% of stocks in the mega market cap category.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Abbott Laboratories's upside potential (average analyst target price relative to current price) is higher than 75.4% of them.
  • Abbott Laboratories's number of analysts covering the stock is greater than 906.4% of Pharmaceutical Products stocks.
  • ABT has a greater average analyst price target than 890.38% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Abbott Laboratories are ABBV, TECH, and SGEN.

Is ABT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4248 seconds.